Ardisia japonica
Ardisia japonica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Ardisia japonica is a versatile plant species known for its diverse range of biological activities. Research has highlighted its potential as an antitussive agent, as well as its role as an 11B-HSD-inhibitor, 5-lipoxygenase-inhibitor, and ACE-inhibitor. These medicinal properties are largely attributed to key chemical constituents such as bergenin, cyclamiretin A, norbergenin, and ardimerin digallate. Scientists often study the plant's effects on injury recovery using preparations of the whole plant or methanol extracts of its aerial parts. Consequently, this species remains a subject of significant interest in pharmacological studies.
- Synonyms
- Tinus Japonica · Bladhia Japonica
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Ardisia japonica is a versatile plant known by a variety of names across different languages and regions. In English-speaking areas, it is frequently referred to by the common names Japanese ardisia or marlberry. Those familiar with German terminology might recognize it as the Mergelbeere. Meanwhile, in Czech, the species is identified as either ardízia japonská or klíman japonský. These diverse names highlight the global presence and cultural recognition of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Ardisia japonica is a distinctive plant that is often recognized by various botanical names within scientific literature. Due to shifts in taxonomic classification, it is frequently referred to by its synonym, Bladhia japonica. Similarly, researchers may encounter the name Tinus japonica when documenting this specific species. These differing designations reflect the complex history of plant nomenclature and evolving botanical studies. Understanding these synonyms is essential for anyone seeking to accurately identify the plant in a professional context.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Ardisia japonica is a member of the kingdom Plantae, placing it firmly within the world of vegetation. This specific plant belongs to the genus Ardisia, which defines its primary botanical classification. Within this group, it is categorized under the order Ericales to further refine its lineage. It also falls under the family Primulaceae, highlighting its close evolutionary ties to related species. Finally, the plant is classified under the class Equisetopsida, completing its detailed taxonomic profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Ardisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ardisia japonica is a resilient species primarily distributed throughout the temperate regions of Asia. In China, its presence is widespread, spanning from the North-Central territories to the South-Central and Southeast provinces. The plant also finds a natural home across Eastern Asia, establishing itself firmly within the landscapes of both Japan and Korea. This broad geographic range highlights the plant's ability to thrive in various ecological niches across the continent. Consequently, understanding these regional distributions is essential for studying the species' ecological impact.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ardisia japonica is characterized by its distinctive shrub-like growth form. This plant remains entirely self-supporting as it matures within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Ardisia japonica serves as a vital medicinal resource due to its ability to produce bergenin, a key component in cough relief. This specific carbon glycoside is widely utilized in China as a primary active ingredient in antitussive drugs designed for central cough inhibition. Recent scientific research has focused on uncovering the complex biosynthetic pathway that allows this plant to synthesize such a valuable compound. By characterizing specific enzymes like O-methyltransferases and glycosyltransferases, researchers have mapped how the plant transforms shikimic acid into bergenin. These findings offer a significant breakthrough that could eventually allow for the rational production of antitussive agents through synthetic biology.
Compounds
Ardisia japonica serves as a rich botanical source for a diverse array of bioactive chemical constituents. Research has identified that this medicinal plant contains bergenin, a primary active ingredient often used in antitussive drugs. Furthermore, the species is known to contain norbergenin, which has demonstrated weak in vitro anti-HIV activity. The chemical profile of the plant also includes cyclamiretin A, which serves as an aglycone moiety in certain triterpene glycosides. Additionally, the isolation of the dimeric lactone ardimerin digallate from the whole plant has revealed its potential to inhibit HIV-1 and HIV-2 ribonuclease H.
Conditions
Ardisia japonica demonstrates significant therapeutic potential through its various bioactive compounds. The plant contains triterpenoid saponins that exhibit cytotoxic activities against A549 lung adenocarcinoma, HL-60 myeloid leukemia, and KATO-III stomach adenocarcinoma cells. Furthermore, extracts from the plant include a dimeric lactone known as ardimerin digallate. This specific compound provides inhibitory activity against both HIV-1 and HIV-2 ribonuclease H. These diverse biological activities highlight the medicinal versatility of the species against both cancer and viral targets.
Preparations
Ardisia japonica is utilized in research both as whole plants and as a MeOH extract of its aerial parts. When prepared as whole plants, various triterpenoid saponins and a dimeric lactone known as ardimerin digallate were successfully isolated. These whole-plant extracts have been studied for their cytotoxic activities against specific human cancer cell lines and their inhibitory effects on HIV ribonuclease H. Conversely, the MeOH extract of the aerial parts was specifically screened for its potential as an anti-AIDS agent. This particular preparation demonstrated moderate in vitro anti-HIV activity, which was later attributed to compounds such as bergenin and norbergenin.